1.
Med J Aust
; 204(7): 277-8, 2016 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27078606
Assuntos
Proteínas de Bactérias/biossíntese , Farmacorresistência Bacteriana , Klebsiella pneumoniae/enzimologia , beta-Lactamases/biossíntese , Compostos Azabicíclicos/uso terapêutico , Carbapenêmicos/farmacologia , Ceftazidima , Humanos , Infecções por Klebsiella/tratamento farmacológico , Klebsiella pneumoniae/efeitos dos fármacos , Masculino , Metronidazol/uso terapêutico , Pessoa de Meia-Idade , Pancreatopatias/microbiologia , Teicoplanina/uso terapêutico
2.
Aust N Z J Obstet Gynaecol
; 51(4): 372-6, 2011 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21806575
RESUMO
Trastuzumab increases survival amongst women with human epidermal growth factor receptor (HER)-2 receptor positive metastatic breast cancer, but maternal and fetal risks are associated with advanced disease and its treatment in pregnancy. We present a case of a primigravid with HER-2 positive metastatic breast cancer who received trastuzumab throughout pregnancy. She presented with cerebral metastases, requiring surgical decompression and resection. Reversible oligohydramnios developed during pregnancy. Fetal safety data on trastuzumab in pregnancy is limited, but case reports suggest a recurring pattern of (mostly reversible) oligohydramnios.